Cryoport, Inc., the world’s leading temperature-controlled logistics company dedicated to the life sciences industry, today announced that it has expanded its suite of temperature-controlled solutions to include biostorage for the life sciences through its acquisition of Cryogene Partners, a Houston-based company. Cryogene operates a recently expanded 21,000 square foot state-of-the-art biostorage facility, specializing in the secure storage of biological specimens, materials and samples. The acquisition is structured as an asset purchase and is expected to be immediately accretive to Cryoport’s earnings.
Cryogene is an industry leader in the management of critical biological commodities to support the advancement of cell and gene therapies, GMP biologics, and public health research. It provides customized, end-to-end chain of custody solutions for its clients. Cryogene has an impeccable reputation and has long-term contracts with Merck, MD Anderson, Houston Methodist Hospital, Texas Children’s Hospital, Mesoblast, Bellicum, Baylor University, and many other noted institutions due to its proven reliability.
Cryogene’s well equipped facilities store clients’ commodities covering the full range of temperatures from cryogenic through controlled room temperature. Its services include sample inventorying, data sample discrepancy resolution and accessioning samples into its validated data inventory software. Cryogene is ISO 9001 compliant, registered and inspected by the Food and Drug Administration; is routinely inspected by the Foundation for the Accreditation of Cellular Therapy as a storage supplier for accredited cell banks; and manages its inventories by a validated sample inventory software system.
Cryogene’s stellar reputation complements that of Cryoport’s as a provider of best-in-class temperature-controlled supply chain management solutions for the life sciences. Cryoport’s expansive suite of solutions includes its Cryoportal® Logistics Management Platform, Smartpak II™ Condition Monitoring System and around-the-clock customer support and intervention capability.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
This acquisition expands the Company’s portfolio of services, allowing Cryoport to continue to leverage the rapid growth in the regenerative medicine market as industry-wide investment in this market continues to grow. It also begins to answer and respond to a growing number of inquiries from Cryoport’s existing client base for a more complete “end-to-end” material management solution inclusive of bioservices tailored to the regenerative medicine market.
Marshall Griswold, Chief Executive Officer of Cryogene and the managing founder stated, “On behalf of all the employees at Cryogene, I can say we are proud to be a part of Cryoport and its industry leading initiatives that provide the life sciences with unparalleled logistics solutions, and now, biostorage solutions. We have been building our business over the past fourteen years and it is, indeed, refreshing to be propelled into helping build a larger and greater endeavor, which will provide revolutionary services in the rapidly developing life sciences industry. Of course, with Cryogene as a part of Cryoport, we plan to accelerate Cryogene’s growth, but our focus at Cryogene will remain on our loyal, long-term clients that put their trust in us every day.”
Jerrell Shelton, CEO of Cryoport, said, “We welcome the Cryogene team; they will be an important part of Cryoport as we move forward with the addition of temperature-controlled bioservices capabilities. By adding Cryogene to its family, Cryoport is further building out its ecosystem to better serve the life sciences and, especially, regenerative therapy. After months of careful research and discussions with the Cryogene team, we were impressed by their focus on clients, quality, regulatory compliance, technology, and monitoring solutions that protect high-value and sensitive biopharmaceutical commodities during storage. We determined that Cryogene’s commitment to quality is closely aligned with Cryoport’s values and makes Cryogene an excellent strategic and operational fit for our continuing development.”
Mr. Shelton continued, “Cryogene has established an impressive client roster, demonstrating the strength of demand for high quality temperature-controlled biostorage options from the biopharma market. Over time, we plan for Cryogene to build on its strong foundation by expanding its services and its footprint.”
Date: May 20, 2019
Source: Yahoo Finance